姓名：徐俊杰

性别：男

最高学位：博士

职称：教授

工作单位：长治医学院

电子邮件：xjjcmu@163.com

导师类型：硕士生导师

专业学位领域：105300 公共卫生

研究方向：疾病预防控制

简介：

徐俊杰：男，汉族，1976年8月生，中共党员，医学博士，教授，博导，中国医科大学、长治医学院研究生导师，辽宁省领军人才，深圳市地方领军人才；Journal of Clinical Medicine、中国艾滋病性病杂志编委；主要从事传染病流行病学、临床试验研究、循证医学研究、医疗大数据开发等相关研究；累积主持国家、省部级科研课题十余项；在Lancet HIV、JAMA Network Open、JMIR等杂志发表国际高水平SCI论文140余篇（第一/通讯作者SCI论文80余篇），被引用2900余次；获得国家科技进步二等奖一项。

代表性科研项目：

1、HIV感染风险在线预测预警对MSM人群HIV新发感染及相关高危行为的影响研究，国家自然基金面上项目

2、基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究，国家自然基金面上项目

3、基20220282免疫缺陷人群新冠疫苗接种模式研究，深圳市科创委重点项目

4、HIV感染者接种新冠灭活疫苗加强针的安全性、免疫原性的前瞻性队列研究，横向课题

代表性学术成果：

1、Li S, Zhang J, Mao X, Lu T, Gao Y, Zhang W, Wang H, Chu Z, Hu Q, Jiang Y, Geng W, Shang H, Xu J. Feasibility of Indirect Secondary Distribution of HIV Self-test Kits via WeChat Among Men Who Have Sex With Men: National Cross-sectional Study in China. J Med Internet Res. 2021 Oct 26;23(10): e28508. doi: 10.2196/28508. PMID: 34698651; PMCID: PMC8579221.

2、Zhang J*, Xu JJ*, Wang HY, Huang XJ, Chen YK, Wang H, Chu ZX, Hu QH, He XQ, Li Y, Zhang LK, Hu ZL, Bao RT, Li SC, Li H, Ding HB, Jiang YJ, Geng WQ, Sylvia S, Shang H; CROPrEP Group. Preference for daily versus on-demand pre-exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real-world Oral PrEP Demonstration study. J Int AIDS Soc. 2021 Feb;24(2): e25667. doi: 10.1002/jia2.25667. Erratum in: J Int AIDS Soc. 2021 Jun;24(6): e25754. doi: 10.1002/jia2.25754. PMID: 33586841; PMCID: PMC7883476.

3、Xu J, Tang W, Zhang F, Shang H. PrEP in China: choices are ahead. Lancet HIV. 2020 Mar;7(3): e155-e157. doi: 10.1016/S2352-3018(19)30293-0. Epub 2019 Aug 28. Erratum in: Lancet HIV. 2019 Dec;6(12): e815. doi: 10.1016/S2352-3018(19)30321-2. PMID: 31473165.

4、Hu QH, Qian HZ, Li JM, Leuba SI, Chu ZX, Turner D, Ding HB, Jiang YJ, Vermund SH, Xu JJ*, Shang H*. Assisted Partner Notification and Uptake of HIV Testing among Men Who Have Sex with Men: A Randomized Controlled Trial in China. Lancet Reg Health West Pac. 2021 Jun 10; 12: 100171. doi: 10.1016/j.lanwpc.2021.100171. PMID: 34527967; PMCID: PMC8356101.

5、Wang J*, Yuan T*, Ding H*, Xu J*, Keusters WR, Ling X, Fu L, Zhu Q, Li Q, Tang X, Cai W, Shang H, Li L, Zou H. Development and external validation of a prognostic model for survival of people living with HIV/AIDS initiating antiretroviral therapy. Lancet Reg Health West Pac. 2021 Sep 7; 16: 100269. doi: 10.1016/j.lanwpc.2021.100269. PMID: 34590068; PMCID: PMC8427312.

6、Zhang J*, Li C*, Xu J*, Hu Z, Rutstein SE, Tucker JD, Ong JJ, Jiang Y, Geng W, Wright ST, Cohen MS, Shang H, Tang W. Discontinuation, suboptimal adherence, and reinitiation of oral HIV pre-exposure prophylaxis: a global systematic review and meta-analysis. Lancet HIV. 2022 Apr; 9(4): e254-e268. doi: 10.1016/S2352-3018(22)00030-3. PMID: 35364026; PMCID: PMC9124596.

7、Ye ZH, Liu F, Chu ZX, Duan JY, Yang J, Zheng JX, Bi XY, Ding HB, Jiang YJ, Xu JJ*, Hu QH*, Shang H*. Effectiveness and safety of community-led assisted partner service among HIV-diagnosed men who have sex with men: a multicentre, randomized controlled trial in China. Lancet Reg Health West Pac. 2023 May 16; 36: 100772. doi: 10.1016/j.lanwpc.2023.100772. PMID: 37547042; PMCID: PMC10398600.

8、Wu X, Wu G, Ma Y, Huang X, Yang Y, Cai Y, Luo G, Ma P, Qiao Y, Chen Y, Lin YF, Gao Y, Zhan Y, Song W, Wang Y, Wang R, Yang X, Sun L, Wei H, Li Q, Xin X, Wang L, Wang X, Xie R, Yang L, Meng X, Zhao J, Li L, Zhang T, Xu J*, Fu G*, Zou H*. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis. Lancet Reg Health West Pac. 2022 Aug 10; 29: 100569. doi: 10.1016/j.lanwpc.2022.100569. PMID: 35966023; PMCID: PMC9365399.